Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.

Authors :: Guillermin Y
Herbaux C
Subtil F
Aurran-Schleinitz T
Cymbalista F
Letestu R
Leprêtre S
Vaudaux S
Laribi K
Leblond V
Defoi Y
Benchikh R
Salles G
Godmer P
Jardel H
Vallais F
Feugier P
Orsini F
Pegourié B
Lévy V
Michallet AS
Source :: American journal of hematology [Am J Hematol] 2018 Jan; Vol. 93 (1), pp. E24-E27. Date of Electronic Publication: 2017 Nov 17.
Publication Year :: 2018

Subjects :: Cyclophosphamide therapeutic use
Follow-Up Studies
Humans
Remission Induction
Retrospective Studies
Vidarabine analogs & derivatives
Vidarabine therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy

Full Text Access

Tools